Medication info
Metin M Tablet 20 mg (Memantine Hydrochloride)

Metin M Tablet 20 mg (Memantine Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Memantine Hydrochloride›20mg / 1 tablet
Manufacturer / importer
Mothers Pharmaceutical Co., Ltd.
Appearance
Pink rectangular film-coated tablets
Packaging
30 tablets/bottle [bottle: HDPE, cap: LDPE], 100 tablets/bottle [bottle: HDPE, cap: LDPE]
Approval status
Active

MFDS item code 202500154 · Approved 2025.01.21 · Insurance code 622805450

Summary

Main use
Treatment of moderate to severe Alzheimer's disease
Who takes it
Adults
Adult dose
Administer this medicine orally once daily at the same time each day. If necessary, this medicine may be administered twice daily. It may be taken with or without food. 1. Adults Dose titration: The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg per week over the first 3 weeks as follows to reach the maintenance dose. Week 1 (Days 1-7) Administer 5mg once daily for 7 days. Week 2 (Days 8-14) Administer 10mg once daily for 7 days. Week 3 (Days 15-21) Administer 15mg once daily for 7 days. From Week 4 onward Administer 20mg once daily. Maintenance dose: The recommended maintenance dose is 20mg once daily. 2. Elderly patients Based on clinical data, the recommended dose for elderly patients aged 65 years and older is 20mg once daily. 3. Patients with renal impairment No dose adjustment is necessary in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance: 30-49 mL/min), reduce the daily dose to 10mg. If tolerated well for at least 7 days, the dose may be increased to 20mg daily according to the standard dose-titration method. In patients with severe renal impairment (creatinine clearance: 5-29 mL/min), reduce the daily dose to 10mg. 4. Patients with hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). Since there are no data on the use of memantine in patients with severe hepatic impairment, administration of this medicine is not recommended.

Ingredients

Manufacturer
Mothers Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of moderate to severe Alzheimer's disease

View approved original text

This medication is used in the treatment of moderate to severe Alzheimer's disease. Alzheimer's disease is a condition characterized by severe impairment of memory and cognitive function; this medication helps alleviate these symptoms and improve quality of life.

How to take

Adult dose

Administer this medicine orally once daily at the same time each day. If necessary, this medicine may be administered twice daily. It may be taken with or without food. 1. Adults Dose titration: The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg per week over the first 3 weeks as follows to reach the maintenance dose. Week 1 (Days 1-7) Administer 5mg once daily for 7 days. Week 2 (Days 8-14) Administer 10mg once daily for 7 days. Week 3 (Days 15-21) Administer 15mg once daily for 7 days. From Week 4 onward Administer 20mg once daily. Maintenance dose: The recommended maintenance dose is 20mg once daily. 2. Elderly patients Based on clinical data, the recommended dose for elderly patients aged 65 years and older is 20mg once daily. 3. Patients with renal impairment No dose adjustment is necessary in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance: 30-49 mL/min), reduce the daily dose to 10mg. If tolerated well for at least 7 days, the dose may be increased to 20mg daily according to the standard dose-titration method. In patients with severe renal impairment (creatinine clearance: 5-29 mL/min), reduce the daily dose to 10mg. 4. Patients with hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). Since there are no data on the use of memantine in patients with severe hepatic impairment, administration of this medicine is not recommended.

Precautions

This medication should not be administered to certain patients. First, individuals allergic to any components of this medication should not use it. Furthermore, patients with severely impaired liver function or significantly poor kidney function may be at risk when taking this medication. Caution should be exercised when using this medication in patients with epilepsy or those who have a history of seizures or are prone to seizures. Additionally, if taking certain drugs such as amantadine, ketamine, or dextromethorphan, the risk of side effects may be increased, so it is advisable to avoid concurrent use. Patients with conditions or dietary changes that could affect the acidity (pH) of urine should also be carefully monitored when taking this medication. Caution is required as the safety of this medication has not been sufficiently confirmed in patients with uncontrolled heart disease or hypertension. When taking this medication, side effects such as dizziness, headache, constipation, drowsiness, and hypertension may occur. If these symptoms are severe or persist, consult a healthcare professional. This medication may interact with other drugs, so it is important to discuss with a doctor or pharmacist when taking medications that affect the nervous system or blood coagulation. Pregnant women or those who may become pregnant should consult a doctor before taking this medication, and breastfeeding women are advised to stop breastfeeding while on this medication. The safety and efficacy of this medication in children and adolescents under 18 years of age have not been established, so usage is not recommended. In cases of overdose, severe symptoms such as coma, hallucinations, or seizures may occur, so seek immediate medical attention if overdose is suspected. This medication may reduce the speed of patient response and concentration; therefore, special care is required when driving or operating machinery. Finally, this medication should be kept out of reach of children, and it is advisable to avoid transferring it to other containers.

Side effects

  • Dizziness
  • headache
  • constipation
  • drowsiness
  • hypertension
  • fungal infection
  • drug hypersensitivity reaction
  • drowsiness
  • confusion
  • hallucination
Show 33 more
  • psychotic reaction
  • dizziness
  • balance disorder
  • gait abnormality
  • seizure
  • heart failure
  • hypertension
  • venous thrombosis
  • thromboembolism
  • dyspnea
  • constipation
  • vomiting
  • pancreatitis
  • elevated liver function test results
  • hepatitis
  • headache
  • fatigue
  • tiredness
  • weakness
  • diarrhea
  • confusion
  • drowsiness
  • restlessness
  • aggression
  • hallucination
  • gait disturbance
  • restlessness
  • psychosis
  • visual hallucination
  • convulsion
  • drowsiness
  • confusion
  • unconsciousness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it should be stored in a tightly closed container. Additionally, avoid excessively hot or cold environments, and store it at a safe temperature between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

Pink rectangular film-coated tablets

Package unit

30 tablets/bottle [bottle: HDPE, cap: LDPE], 100 tablets/bottle [bottle: HDPE, cap: LDPE]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.